New weapon against superbug pneumonia enters human testing
Disease control
Not yet recruiting
This early-stage study tests a new drug called MP101 in 18 adults with a serious lung infection caused by Pseudomonas aeruginosa bacteria. The drug is given once through a vein along with standard antibiotics. The main goal is to check if MP101 is safe and tolerable, and to see h…
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated May 07, 2026 18:41 UTC